pro medicus - PMCUF

PMCUF

Close Chg Chg %
205.00 1.00 0.49%

Closed Market

206.00

+1.00 (0.49%)

Volume: 243.00

Last Updated:

Aug 6, 2025, 11:41 AM EDT

Company Overview: pro medicus - PMCUF

PMCUF Key Data

Open

$206.00

Day Range

206.00 - 206.00

52 Week Range

80.09 - 218.25

Market Cap

$21.66B

Shares Outstanding

104.46M

Public Float

52.97M

Beta

1.26

Rev. Per Employee

N/A

P/E Ratio

330.22

EPS

N/A

Yield

15.12%

Dividend

$0.16

EX-DIVIDEND DATE

Feb 27, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

445.81

 

PMCUF Performance

1 Week
 
1.56%
 
1 Month
 
1.23%
 
3 Months
 
73.66%
 
1 Year
 
127.25%
 
5 Years
 
N/A
 

PMCUF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About pro medicus - PMCUF

Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. It provides services in the form of installation and support. The firm offers a range of products including radiology information systems, picture archiving and communication systems. It also offers workflow mapping and optimization, network design and implementation, hardware sourcing, and configuration as well as staff and management training. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.

PMCUF At a Glance

Pro Medicus Ltd.
450 Swan Street
Richmond, Victoria (VIC) 3121
Phone 61-3-9429-8800 Revenue 105.83M
Industry Services to the Health Industry Net Income 54.25M
Sector Health Services 2024 Sales Growth 25.967%
Fiscal Year-end 06 / 2025 Employees N/A
View SEC Filings

PMCUF Valuation

P/E Current 330.219
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 184.17
Price to Sales Ratio 94.612
Price to Book Ratio 79.689
Price to Cash Flow Ratio 176.084
Enterprise Value to EBITDA 125.235
Enterprise Value to Sales 93.644
Total Debt to Enterprise Value 0.00

PMCUF Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 3.221
Total Asset Turnover 0.691

PMCUF Liquidity

Current Ratio 5.977
Quick Ratio 5.976
Cash Ratio 4.498

PMCUF Profitability

Gross Margin 75.732
Operating Margin 69.505
Pretax Margin 72.135
Net Margin 51.265
Return on Assets 35.405
Return on Equity 49.831
Return on Total Capital 42.802
Return on Invested Capital 49.421

PMCUF Capital Structure

Total Debt to Total Equity 1.102
Total Debt to Total Capital 1.09
Total Debt to Total Assets 0.804
Long-Term Debt to Equity 0.808
Long-Term Debt to Total Capital 0.799
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Pro Medicus - PMCUF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
50.64M 67.78M 84.01M 105.83M
Sales Growth
+32.94% +33.85% +23.96% +25.97%
Cost of Goods Sold (COGS) incl D&A
15.83M 16.81M 21.88M 25.68M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.37M 5.31M 5.33M 5.58M
Depreciation
598.99K 589.58K 561.66K 555.03K
Amortization of Intangibles
4.77M 4.72M 4.77M 5.02M
COGS Growth
+13.04% +6.19% +30.18% +17.36%
Gross Income
34.81M 50.97M 62.13M 80.15M
Gross Income Growth
+44.51% +46.43% +21.90% +29.00%
Gross Profit Margin
+68.74% +75.20% +73.95% +75.73%
2021 2022 2023 2024 5-year trend
SG&A Expense
3.19M 5.72M 5.71M 6.59M
Research & Development
- - - -
-
Other SG&A
3.19M 5.72M 5.71M 6.59M
SGA Growth
-18.75% +79.22% -0.22% +15.36%
Other Operating Expense
- - - -
-
Unusual Expense
(2.24K) 1.69M 199.78K (701.81K)
EBIT after Unusual Expense
31.61M 43.56M 56.22M 74.26M
Non Operating Income/Expense
365.51K 2.19M 1.72M 2.08M
Non-Operating Interest Income
134.27K 470.65K 1.64M 3.17M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
31.98M 45.74M 57.93M 76.34M
Pretax Income Growth
+58.91% +43.04% +26.64% +31.77%
Pretax Margin
+63.15% +67.49% +68.96% +72.13%
Income Tax
8.97M 13.52M 17.14M 22.09M
Income Tax - Current - Domestic
9.54M 13.42M 18.59M 23.23M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(573.63K) 93.55K (1.45M) (1.14M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
23.01M 32.23M 40.79M 54.25M
Minority Interest Expense
- - - -
-
Net Income
23.01M 32.23M 40.79M 54.25M
Net Income Growth
+48.76% +40.05% +26.58% +32.99%
Net Margin Growth
+45.45% +47.55% +48.56% +51.27%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
23.01M 32.23M 40.79M 54.25M
Preferred Dividends
- - - -
-
Net Income Available to Common
23.01M 32.23M 40.79M 54.25M
EPS (Basic)
0.2209 0.309 0.3907 0.5195
EPS (Basic) Growth
+48.35% +39.88% +26.44% +32.97%
Basic Shares Outstanding
104.17M 104.31M 104.41M 104.44M
EPS (Diluted)
0.22 0.3082 0.3901 0.5184
EPS (Diluted) Growth
+48.55% +40.09% +26.57% +32.89%
Diluted Shares Outstanding
104.59M 104.58M 104.59M 104.65M
EBITDA
36.98M 50.55M 61.75M 79.13M
EBITDA Growth
+46.14% +36.68% +22.16% +28.16%
EBITDA Margin
+73.03% +74.58% +73.50% +74.77%

Pro Medicus in the News